Reports

14158 Results (Page 533 of 567)

All Market Research Reports

Pharmaceuticals

Japan Dental Fluoride Treatment Market Analysis

The Japan Dental Fluoride Treatment Market was valued at $942.8 Mn in 2023 and is projected to grow at a CAGR of 4.4% from 2023 to 2023, to $1,274.4 Mn by 2030. The key drivers of this industry are growing prevalence of dental caries coupled with increasing awareness regarding oral health and hygiene, increasing the intake of sugary drinks and food, projected to drive the market. The industry is primarily dominated by players such as Lion Corporation, Sunstar Group, Kao Corporation, GlaxoSmithKline, and Procter & Gamble among others.

PUBLISHED: Aug, 2024 | FORMAT: PPT | LAST UPDATED: Aug, 2024 | PRICE: $3999

Pharmaceuticals

Brazil Cold Pain Therapy Market Analysis

The Brazil Cold Pain Therapy Market was valued at $55 Mn in 2022 and is predicted to grow at a CAGR of 6.2% from 2023 to 2030, to $89 Mn by 2030. The key drivers of this industry include the increasing prevalence of pain disorders, demand for non-pharmaceutical alternatives in the industry, and focus on sports medicine and rehabilitation. The industry is primarily dominated by players such as DJO Global, Hisamitsu, Sanofi, Ossur, Rohto, Pfizer, and Cardinal Health among others.

PUBLISHED: May, 2024 | FORMAT: PPT | LAST UPDATED: May, 2024 | PRICE: $3999

Medical Devices

Philippines Hemodialysis Equipment Market Analysis

The Philippines Hemodialysis Equipment Market was valued at $31.1 Mn in 2023 and is projected to grow at a CAGR of 8.1% from 2023 to 2023, to $53.6 Mn by 2030. The key drivers of this industry are increasing incidence of chronic kidney disease (CKD) and end-stage renal disease (ESRD), availability of advanced dialysis machines and consumables, government initiatives to improve dialysis accessibility, growing adoption of home haemodialysis, expansion of dialysis service providers which has contributed to market growth. The industry is primarily dominated by players such as Baxter, B. Braun SE, Fresenius Medical Care AG, Medtronic among others.

PUBLISHED: Jul, 2024 | FORMAT: PPT | LAST UPDATED: Jul, 2024 | PRICE: $3999

Pharmaceuticals

Malaysia Dental Fluoride Treatment Market Analysis

The Malaysia Dental Fluoride Treatment Market was valued at $24.4 Mn in 2023 and is projected to grow at a CAGR of 4.1% from 2023 to 2023, to $32.3 Mn by 2030. The key drivers of this industry are growing prevalence of dental caries coupled with increasing awareness regarding oral health and hygiene, increasing the intake of sugary drinks and food, projected to drive the market. The industry is primarily dominated by players such as Colgate-Palmolive, Sarjana Sumber, Southern Lion, Tohtohku, Kotra Pharma and Hovid Berhad among others.

PUBLISHED: Aug, 2024 | FORMAT: PPT | LAST UPDATED: Aug, 2024 | PRICE: $3999

Healthcare Services

China Financial Assistance Programs Market Analysis

The China Financial Assistance Programs Market was valued at $2,278.1 Mn in 2023 and is projected to grow at a CAGR of 16.1% from 2023 to 2023, to $6,477.4 Mn by 2030. The market is driven by various sector such as rising drug cost, complex insurance landscape, regulatory environment, market competition, patient adherence concern etc. The prominent pharmaceutical companies providing financial assistance to patient are such as CSPC Pharmaceuticals, Cardinal Health, Sinopharm Group Co Ltd, Merck, GSK, Johnson & Johnson, Novartis among others.

PUBLISHED: Sep, 2024 | FORMAT: PPT | LAST UPDATED: Sep, 2024 | PRICE: $3999

Medical Devices

Singapore Hemodialysis Equipment Market Analysis

The Singapore Hemodialysis Equipment Market was valued at $16.9 Mn in 2023 and is projected to grow at a CAGR of 8.2% from 2023 to 2023, to $29.4 Mn by 2030. The key drivers of this industry are increasing incidence of chronic kidney disease (CKD) and end-stage renal disease (ESRD), availability of advanced dialysis machines and consumables, government initiatives to improve dialysis accessibility, growing adoption of home haemodialysis, expansion of dialysis service providers which has contributed to market growth. The industry is primarily dominated by players such as Biosensors International, Everlife, Baxter, B. Braun SE, Fresenius Medical Care AG, Medtronic among others.

PUBLISHED: Jul, 2024 | FORMAT: PPT | LAST UPDATED: Jul, 2024 | PRICE: $3999

Pharmaceuticals

Philippines Dental Fluoride Treatment Market Analysis

The Philippines Dental Fluoride Treatment Market was valued at $33.4 Mn in 2023 and is projected to grow at a CAGR of 4.4% from 2023 to 2023, to $45.1 Mn by 2030. The key drivers of this industry are growing prevalence of dental caries coupled with increasing awareness regarding oral health and hygiene, increasing the intake of sugary drinks and food, projected to drive the market. Furthermore, increasing support from the government to improve access to person-cantered treatment contributed to market growth. The industry is primarily dominated by players such as Lamoiyan Corporation, Colgate, Splash Corporation, Dentsply Sirona, VOCO, among others.

PUBLISHED: Aug, 2024 | FORMAT: PPT | LAST UPDATED: Aug, 2024 | PRICE: $3999

Healthcare Services

Indonesia Financial Assistance Programs Market Analysis

The Indonesia Financial Assistance Programs Market was valued at $170 Mn in 2023 and is projected to grow at a CAGR of 14.6% from 2023 to 2023, to $441.4 Mn by 2030. The market is driven by various sector such as rising drug cost, complex insurance landscape, regulatory environment, market competition, patient adherence concern etc. The prominent pharmaceutical companies providing financial assistance to patient are such as Mayer, Cipla, Merck, GSK, Johnson & Johnson, Novartis among others.

PUBLISHED: Sep, 2024 | FORMAT: PPT | LAST UPDATED: Sep, 2024 | PRICE: $3999

Pharmaceuticals

China Cold Pain Therapy Market Analysis

The China Cold Pain Therapy Market was valued at $177 Mn in 2022 and is predicted to grow at a CAGR of 6.7% from 2023 to 2030, to $297 Mn by 2030. The key drivers of this industry include the rising prevalence of chronic pain disorders, technological advances in the industry, and changing consumer preferences. The industry is primarily dominated by players such as Meditech, Beijing Beike, Ossur, Shanghai Olympus, Pfizer, and Hisamitsu among others.

PUBLISHED: May, 2024 | FORMAT: PPT | LAST UPDATED: May, 2024 | PRICE: $3999

Medical Devices

South Africa Hemodialysis Equipment Market Analysis

The South Africa Hemodialysis Equipment Market was valued at $91.8 Mn in 2023 and is projected to grow at a CAGR of 8.83% from 2023 to 2023, to $165.9 Mn by 2030. The key drivers of this industry are increasing incidence of chronic kidney disease (CKD) and end-stage renal disease (ESRD), availability of advanced dialysis machines and consumables, government initiatives to improve dialysis accessibility, growing adoption of home haemodialysis, expansion of dialysis service providers which has contributed to market growth. The industry is primarily dominated by players such as Toray Industries Inc, Angiodynamics Inc, Baxter, B. Braun SE, Fresenius Medical Care AG, Medtronic among others.

PUBLISHED: Jul, 2024 | FORMAT: PPT | LAST UPDATED: Jul, 2024 | PRICE: $3999

Pharmaceuticals

Singapore Dental Fluoride Treatment Market Analysis

The Singapore Dental Fluoride Treatment Market was valued at $18.2 Mn in 2023 and is projected to grow at a CAGR of 4.5% from 2023 to 2023, to $24.8 Mn by 2030. The key drivers of this industry are growing prevalence of dental caries coupled with increasing awareness regarding oral health and hygiene, increasing the intake of sugary drinks and food, projected to drive the market. The industry is primarily dominated by players such as Pearlie White, Zenyum, Pigeon Singapore, Unilever, P & G among others

PUBLISHED: Aug, 2024 | FORMAT: PPT | LAST UPDATED: Aug, 2024 | PRICE: $3999

Healthcare Services

Japan Financial Assistance Programs Market Analysis

The Japan Financial Assistance Programs Market was valued at $1,761.5 Mn in 2023 and is projected to grow at a CAGR of 15.1% from 2023 to 2023, to $4,714.3 Mn by 2030. The market is driven by various sector such as rising drug cost, complex insurance landscape, regulatory environment, market competition, patient adherence concern etc. The prominent pharmaceutical companies providing financial assistance to patient are such as Daiichi Sankyo Co Ltd, Takeda, Bayer, Baxter, GSK, Johnson & Johnson, Sanofi among others.

PUBLISHED: Sep, 2024 | FORMAT: PPT | LAST UPDATED: Sep, 2024 | PRICE: $3999

Pharmaceuticals

Egypt Cold Pain Therapy Market Analysis

The Egypt Cold Pain Therapy Market was valued at $6 Mn in 2022 and is predicted to grow at a CAGR of 6.7% from 2023 to 2030, to $10 Mn by 2030. The key drivers of this industry include the rising burden of chronic pain disorders, expanded product offerings, and supportive government initiatives. The industry is primarily dominated by players such as Ossur, Rohto, Pfizer, Hisamitsu, Johnson & Johnson, Sanofi, and Breg among others.

PUBLISHED: May, 2024 | FORMAT: PPT | LAST UPDATED: May, 2024 | PRICE: $3999

Medical Devices

Vietnam Hemodialysis Equipment Market Analysis

The Vietnam Hemodialysis Equipment Market was valued at $70.6 Mn in 2023 and is projected to grow at a CAGR of 7.83% from 2023 to 2023, to $119.7 Mn by 2030. The key drivers of this industry are increasing incidence of chronic kidney disease (CKD) and end-stage renal disease (ESRD), availability of advanced dialysis machines and consumables, government initiatives to improve dialysis accessibility, growing adoption of home haemodialysis, expansion of dialysis service providers which has contributed to market growth. The industry is primarily dominated by players such as Baxter, B. Braun SE, Fresenius Medical Care AG, Medtronic among others.

PUBLISHED: Jul, 2024 | FORMAT: PPT | LAST UPDATED: Jul, 2024 | PRICE: $3999

Pharmaceuticals

Vietnam Dental Fluoride Treatment Market Analysis

The Vietnam Dental Fluoride Treatment Market was valued at $75.8 Mn in 2023 and is projected to grow at a CAGR of 4.13% from 2023 to 2023, to $100.7 Mn by 2030. The key drivers of this industry are growing prevalence of dental caries coupled with increasing awareness regarding oral health and hygiene, increasing the intake of sugary drinks and food, projected to drive the market. The industry is primarily dominated by players such as are Colgate Palmolive, GSK, Unilever, P&G, Sanofi among others.

PUBLISHED: Aug, 2024 | FORMAT: PPT | LAST UPDATED: Aug, 2024 | PRICE: $3999

Healthcare Services

Malaysia Financial Assistance Programs Market Analysis

The Malaysia Financial Assistance Programs Market was valued at $45.6 Mn in 2023 and is projected to grow at a CAGR of 14.8% from 2023 to 2023, to $119.7 Mn by 2030. The market is driven by various sector such as rising drug cost, complex insurance landscape, regulatory environment, market competition, patient adherence concern etc. The prominent pharmaceutical companies providing financial assistance to patient are such as Abbott, AstraZeneca, Johnson & Johnson, Novartis among others.

PUBLISHED: Sep, 2024 | FORMAT: PPT | LAST UPDATED: Sep, 2024 | PRICE: $3999

Pharmaceuticals

France Cold Pain Therapy Market Analysis

The France Cold Pain Therapy Market was valued at $61 Mn in 2022 and is predicted to grow at a CAGR of 4.2% from 2023 to 2030, to $84 Mn by 2030. The key drivers of this industry include the increasing prevalence of pain disorders, technological advances in the industry, and supportive government initiatives. The industry is primarily dominated by players such as DJO Global, Hisamitsu, Custom Ice, Ossur, Medline, Pfizer, and Performance Health among others.

PUBLISHED: May, 2024 | FORMAT: PPT | LAST UPDATED: May, 2024 | PRICE: $3999

Pharmaceuticals

Canada Periodontal Therapeutics Market Analysis

The Canada Periodontal Therapeutics Market was valued at $69.8 Mn in 2023 and is predicted to grow at a CAGR of 7.2% from 2023 to 2030, to $113.6 Mn by 2030. Canada Periodontal Therapeutics Market is growing due to Prevalence of periodontitis, Rise in Demand for Non-surgical Periodontal Therapies, and Emphasis on Preventive Oral Care. The market is primarily dominated by players such as Pfizer Inc., Lupin Ltd, Teva Pharmaceuticals USA, Sun Pharmaceutical Industries Ltd, Tokyo Chemical Industry Co. Ltd., and Bausch Health Companies Inc.

PUBLISHED: Jul, 2024 | FORMAT: PPT | LAST UPDATED: Jul, 2024 | PRICE: $3999

Healthcare Services

Singapore Financial Assistance Programs Market Analysis

The Singapore Financial Assistance Programs Market was valued at $34 Mn in 2023 and is projected to grow at a CAGR of 15.2% from 2023 to 2023, to $91.6 Mn by 2030. The market is driven by various sector such as rising drug cost, complex insurance landscape, regulatory environment, market competition, patient adherence concern etc. The prominent pharmaceutical companies providing financial assistance to patient are such as Abbott, AstraZeneca, GSK among others.

PUBLISHED: Sep, 2024 | FORMAT: PPT | LAST UPDATED: Sep, 2024 | PRICE: $3999

Pharmaceuticals

Germany Cold Pain Therapy Market Analysis

The Germany Cold Pain Therapy Market was valued at $81 Mn in 2022 and is predicted to grow at a CAGR of 3.4% from 2023 to 2030, to $105 Mn by 2030. The key drivers of this industry include a surge in the prevalence of pain disorders, technological advances in the industry, and increasing product innovation. The industry is primarily dominated by players such as DJO Global, Hisamitsu, Beiersdorf, Ossur, Medline, Pfizer, and Cardinal Health among others.

PUBLISHED: May, 2024 | FORMAT: PPT | LAST UPDATED: May, 2024 | PRICE: $3999

Pharmaceuticals

US Periodontal Therapeutics Market Analysis

The US Periodontal Therapeutics Market was valued at $366.6 Mn in 2023 and is predicted to grow at a CAGR of 5.2% from 2023 to 2030, to $522.7 Mn by 2030. The US Periodontal Therapeutics Market is growing due to Rise in prevalence of periodontitis, Emphasis on Preventive Oral Care, and Technological Developments. The market is primarily dominated by players such as Pfizer Inc., Lupin Ltd, Teva Pharmaceuticals USA, Sun Pharmaceutical Industries Ltd, Tokyo Chemical Industry Co. Ltd., and Bausch Health Companies Inc.

PUBLISHED: Jul, 2024 | FORMAT: PPT | LAST UPDATED: Jul, 2024 | PRICE: $3999

Pharmaceuticals

Egypt Dental Fluoride Treatment Market Analysis

The Egypt Dental Fluoride Treatment Market was valued at $42.5 Mn in 2023 and is projected to grow at a CAGR of 5.4% from 2023 to 2023, to $61.4 Mn by 2030. The key drivers of this industry are growing prevalence of dental caries coupled with increasing awareness regarding oral health and hygiene, increasing the intake of sugary drinks and food, projected to drive the market. The industry is primarily dominated by players such as Sigma Pharmaceuticals Industries, Arab Drug Company, MACRO Group, Pharco Pharmaceuticals and Hindustan Unilever Limited among others.

PUBLISHED: Aug, 2024 | FORMAT: PPT | LAST UPDATED: Aug, 2024 | PRICE: $3999

Healthcare Services

Philippines Financial Assistance Programs Market Analysis

The Philippines Financial Assistance Programs Market was valued at $62.3 Mn in 2023 and is projected to grow at a CAGR of 15.1% from 2023 to 2023, to $166.9 Mn by 2030. The market is driven by various sector such as rising drug cost, complex insurance landscape, regulatory environment, market competition, patient adherence concern etc. The prominent pharmaceutical companies providing financial assistance to patient are such as Sanofi, Pfizer, GSK, among others.

PUBLISHED: Sep, 2024 | FORMAT: PPT | LAST UPDATED: Sep, 2024 | PRICE: $3999

Pharmaceuticals

Indonesia Cold Pain Therapy Market Analysis

The Indonesia Cold Pain Therapy Market was valued at $13 Mn in 2022 and is predicted to grow at a CAGR of 5.2% from 2023 to 2030, to $20 Mn by 2030. The key drivers of this industry include the increasing prevalence of chronic pain disorders, expanding product offerings, and growing government investments. The industry is primarily dominated by players such as Kalbe Pharma, Medline, Novell, Ossur, Romsons, Pfizer, and Hisamitsu among others.

PUBLISHED: May, 2024 | FORMAT: PPT | LAST UPDATED: May, 2024 | PRICE: $3999

Pharmaceuticals

Saudi Arabia Periodontal Therapeutics Market Analysis

The Saudi Arabia Periodontal Therapeutics Market was valued at $14.8 Mn in 2023 and is predicted to grow at a CAGR of 8.7% from 2023 to 2030, to $26.6 Mn by 2030. Saudi Arabia Periodontal Therapeutics Market is growing due to Rising Awareness About Dental Hygiene, Prevalence of periodontitis, and Advancements in Treatment Technologies. The market is primarily dominated by players such as Pfizer Inc., Lupin Ltd, Teva Pharmaceuticals USA, Sun Pharmaceutical Industries Ltd, Tokyo Chemical Industry Co. Ltd., and Bausch Health Companies Inc.

PUBLISHED: Jul, 2024 | FORMAT: PPT | LAST UPDATED: Jul, 2024 | PRICE: $3999

subscribe to our newsletter
up